Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Chronic Lymphocytic Leukemia
Age: Between 18 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required